• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区男性中脂质、脂蛋白与良性前列腺增生风险

Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.

作者信息

Parsons J Kellogg, Bergstrom Jaclyn, Barrett-Connor Elizabeth

机构信息

Division of Urology, Department of Surgery, University of California San Diego School of Medicine, La Jolla, CA 21287, USA.

出版信息

BJU Int. 2008 Feb;101(3):313-8. doi: 10.1111/j.1464-410X.2007.07332.x. Epub 2007 Nov 13.

DOI:10.1111/j.1464-410X.2007.07332.x
PMID:18005202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2647139/
Abstract

OBJECTIVE

To examine the associations of serum lipids and lipoproteins with benign prostatic hyperplasia (BPH) in community-dwelling men.

SUBJECTS AND METHODS

This analysis was conducted within the Rancho Bernardo Study, a prospective, community-based cohort study. BPH was defined as a history of prostate surgery for other than cancer, or a medical diagnosis of BPH. Logistic regression modelling, with adjustments for age and stratification by diabetes diagnosis, was used to estimate the odds ratio (OR) of BPH associated with fasting serum concentrations of total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, and the triglyceride to HDL ratio.

RESULTS

Among 531 eligible participants, 259 (48%) reported BPH and 272 (52%) reported no BPH. Men with BPH, with a mean (range) age of 75.8 (76.1-80.1) years, were older than men without BPH , at 72.7 (72.4-74.0) years. There were no significant associations of total cholesterol (P trend, 0.52), HDL cholesterol (0.56), triglycerides (0.30), or triglyceride to HDL ratio (0.13) with the risk of BPH. In a subset analysis in men with diabetes, those in the highest tertile (>133 mg/dL) of LDL cholesterol, compared with those in the lowest tertile (<110 mg/dL), were four times more likely to have BPH (odds ratio 4.00, 95% confidence interval 1.27-12.63, P trend 0.02). These results were not explained by the use of statins.

CONCLUSIONS

In these community-dwelling men, higher serum LDL was associated with a greater risk of BPH among diabetics. These data suggest that diabetic men with increased LDL cholesterol are at greater risk of BPH. This observation is consistent with the concept that cardiac risk factors are involved with the pathogenesis of BPH.

摘要

目的

研究社区男性居民血清脂质和脂蛋白与良性前列腺增生(BPH)之间的关联。

对象与方法

本分析在兰乔贝纳多研究中进行,这是一项基于社区的前瞻性队列研究。BPH定义为非癌症原因的前列腺手术史或BPH的医学诊断。采用逻辑回归模型,并对年龄进行调整,按糖尿病诊断分层,以估计空腹血清总胆固醇、高密度脂蛋白(HDL)胆固醇、低密度脂蛋白(LDL)胆固醇、甘油三酯以及甘油三酯与HDL比值与BPH相关的比值比(OR)。

结果

在531名符合条件的参与者中,259人(48%)报告患有BPH,272人(52%)报告未患BPH。患有BPH的男性平均(范围)年龄为75.8(76.1 - 80.1)岁,比未患BPH的男性年龄大,后者为72.7(72.4 - 74.0)岁。总胆固醇(P趋势,0.52)、HDL胆固醇(0.56)、甘油三酯(0.30)或甘油三酯与HDL比值(0.13)与BPH风险之间无显著关联。在糖尿病男性的亚组分析中,LDL胆固醇处于最高三分位数(>133 mg/dL)的男性与处于最低三分位数(<110 mg/dL)的男性相比,患BPH的可能性高四倍(比值比4.00,95%置信区间1.27 - 12.63,P趋势0.02)。这些结果无法用他汀类药物的使用来解释。

结论

在这些社区男性居民中,较高的血清LDL与糖尿病患者患BPH的风险增加相关。这些数据表明,LDL胆固醇升高的糖尿病男性患BPH的风险更大。这一观察结果与心脏危险因素参与BPH发病机制的概念一致。

相似文献

1
Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.社区男性中脂质、脂蛋白与良性前列腺增生风险
BJU Int. 2008 Feb;101(3):313-8. doi: 10.1111/j.1464-410X.2007.07332.x. Epub 2007 Nov 13.
2
Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects.中国男性受试者中甘油三酯与高密度脂蛋白胆固醇比值、总胆固醇与高密度脂蛋白胆固醇比值及良性前列腺增生风险
Front Nutr. 2022 Oct 3;9:999995. doi: 10.3389/fnut.2022.999995. eCollection 2022.
3
Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.良性前列腺增生年增长率较快的男性的临床、人体测量学、代谢及胰岛素状况
Blood Press. 1999;8(1):29-36. doi: 10.1080/080370599438365.
4
Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease.传统和新型血脂指标与外周动脉疾病风险。
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1229-1238. doi: 10.1161/ATVBAHA.120.315828. Epub 2021 Jan 28.
5
Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.脂蛋白 (a) 与 2 型糖尿病慢性完全闭塞患者造影冠状动脉侧支循环中含胆固醇脂质的相互作用。
Cardiovasc Diabetol. 2019 Jun 24;18(1):82. doi: 10.1186/s12933-019-0888-z.
6
Association between Serum Copper and Serum Lipids in Adults.成人血清铜与血清脂质的关系。
Ann Nutr Metab. 2018;73(4):282-289. doi: 10.1159/000494032. Epub 2018 Oct 26.
7
Seed Extract Attenuates Dyslipidemia in Testosterone Propionate-induced Benign Prostatic Hyperplasia in Rats.种子提取物可减轻丙酸睾酮诱导的大鼠良性前列腺增生中的血脂异常。
Pak J Biol Sci. 2021 Jan;24(1):151-157. doi: 10.3923/pjbs.2021.151.157.
8
Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia.非糖尿病性良性前列腺增生症中的高胰岛素血症和血脂异常
Clin Chim Acta. 2006 Aug;370(1-2):89-93. doi: 10.1016/j.cca.2006.01.019. Epub 2006 Mar 3.
9
Association of insulin levels with lipids and lipoproteins in elderly Japanese-American men.日裔美国老年男性胰岛素水平与脂质及脂蛋白的关联
Ann Epidemiol. 1998 Feb;8(2):92-8. doi: 10.1016/s1047-2797(97)00167-1.
10
Optimal serum cholesterol concentrations are associated with accelerated bone loss in African ancestry men.最佳血清胆固醇浓度与非洲裔男性骨质流失加速有关。
Osteoporos Int. 2016 Apr;27(4):1577-1584. doi: 10.1007/s00198-015-3416-3. Epub 2015 Nov 24.

引用本文的文献

1
SMC Abca1 and Abcg1 Deficiency Enhances Urinary Bladder Distension but Not Atherosclerosis.平滑肌细胞Abca1和Abcg1缺乏增强膀胱扩张但不影响动脉粥样硬化。
Circ Res. 2025 Feb 28;136(5):491-507. doi: 10.1161/CIRCRESAHA.124.325103. Epub 2025 Feb 11.
2
Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.辛伐他汀改善良性前列腺增生:过氧化物酶体增殖物激活受体-γ 和经典 WNT/β-连环蛋白通路的作用。
Int J Mol Sci. 2023 Mar 3;24(5):4911. doi: 10.3390/ijms24054911.
3
Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets.预防良性前列腺增生发展的生活方式习惯:对日本全国数据集的分析
Prostate Int. 2022 Dec;10(4):200-206. doi: 10.1016/j.prnil.2022.06.004. Epub 2022 Jun 28.
4
Associated Factors for Prostate Enlargement in Chinese Adult Men Aged <40 Receiving Checkups.中国 40 岁以下成年男性前列腺增大的相关因素。
Int J Clin Pract. 2022 Aug 11;2022:4792451. doi: 10.1155/2022/4792451. eCollection 2022.
5
Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors.代谢综合征与前列腺增生相关:对下尿路症状因素患者的系统评价、荟萃分析和荟萃回归分析
Ther Adv Endocrinol Metab. 2021 Dec 8;12:20420188211066210. doi: 10.1177/20420188211066210. eCollection 2021.
6
High degree of prostate related LUTS in a prospective cross-sectional community study in Ghana (Mamprobi).在加纳(曼普罗比)进行的一项前瞻性横断面社区研究中,前列腺相关下尿路症状的发生率较高。
Heliyon. 2021 Nov 14;7(11):e08391. doi: 10.1016/j.heliyon.2021.e08391. eCollection 2021 Nov.
7
Endocrinology of the Aging Prostate: Current Concepts.前列腺增龄的内分泌学:当前概念。
Front Endocrinol (Lausanne). 2021 Feb 22;12:554078. doi: 10.3389/fendo.2021.554078. eCollection 2021.
8
The association between metabolic syndrome and lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males: evidence based on propensity score matching.老年男性代谢综合征与提示良性前列腺增生的下尿路症状之间的关联:基于倾向评分匹配的证据
Transl Androl Urol. 2021 Jan;10(1):384-396. doi: 10.21037/tau-20-1127.
9
Increased One-Year Recurrent Ischemic Stroke after First-Ever Ischemic Stroke in Males with Benign Prostatic Hyperplasia.良性前列腺增生男性首次缺血性脑卒中后一年复发缺血性脑卒中增加。
Int J Environ Res Public Health. 2020 Jul 25;17(15):5360. doi: 10.3390/ijerph17155360.
10
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.使用他汀类药物与前列腺体积的纵向变化;多沙唑嗪减少前列腺癌事件研究(REDUCE)的结果。
BJU Int. 2020 Feb;125(2):226-233. doi: 10.1111/bju.14905. Epub 2019 Sep 27.

本文引用的文献

1
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.良性前列腺增生和下尿路症状的可改变风险因素:老问题的新方法
J Urol. 2007 Aug;178(2):395-401. doi: 10.1016/j.juro.2007.03.103. Epub 2007 Jun 11.
2
Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.种族/族裔、肥胖、健康相关行为与有症状良性前列腺增生的风险:前列腺癌预防试验的结果
J Urol. 2007 Apr;177(4):1395-400; quiz 1591. doi: 10.1016/j.juro.2006.11.065.
3
Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement.阿托伐他汀治疗男性下尿路症状和良性前列腺增生。
Eur Urol. 2007 Aug;52(2):503-9. doi: 10.1016/j.eururo.2007.02.032. Epub 2007 Feb 20.
4
Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans.人体测量与代谢因素及良性前列腺增生风险:一项对空军退伍军人的前瞻性队列研究
Urology. 2006 Dec;68(6):1198-205. doi: 10.1016/j.urology.2006.09.034.
5
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.肥胖、糖尿病与前列腺癌风险:前列腺癌预防试验结果
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1977-83. doi: 10.1158/1055-9965.EPI-06-0477.
6
Metabolic factors associated with benign prostatic hyperplasia.与良性前列腺增生相关的代谢因素。
J Clin Endocrinol Metab. 2006 Jul;91(7):2562-8. doi: 10.1210/jc.2005-2799. Epub 2006 Apr 11.
7
Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia.非糖尿病性良性前列腺增生症中的高胰岛素血症和血脂异常
Clin Chim Acta. 2006 Aug;370(1-2):89-93. doi: 10.1016/j.cca.2006.01.019. Epub 2006 Mar 3.
8
Serum lipid levels in benign prostatic hyperplasia.良性前列腺增生症患者的血脂水平
World J Urol. 2006 Jun;24(2):210-3. doi: 10.1007/s00345-006-0062-6. Epub 2006 Feb 28.
9
Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.2型糖尿病、血脂异常与血管风险:纠正脂质失衡的理论依据与证据
Am Heart J. 2005 Nov;150(5):859-70. doi: 10.1016/j.ahj.2005.04.027.
10
The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study.挪威男性尿路症状的患病率及其相关因素:HUNT研究。
BJU Int. 2005 Jul;96(1):88-92. doi: 10.1111/j.1464-410X.2005.05573.x.